Correlation between astrocyte apoptosis and Alzheimer changes in gray matter lesions in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 6, Issue 6, 2004, Pages 623-632

  Kobayashi, Katsuji ^a   Hayashi, Masahiro ^b   Nakano, Hiroyuki ^a,c   Shimazaki, Masao ^a,b   Sugimori, Kaoru ^a   Koshino, Yoshifumi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b National Hospital Organization   (Japan)

^c Takaoka Municipal Hospital   (Japan)

Author keywords

Alzheimer's disease; apoptosis; astrocytes; senile plaques; TUNEL

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; FAS ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN BCL 2; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; CELL DENSITY; CELL LEVEL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE; TISSUE DISTRIBUTION;

EID: 12844271615     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2004-6606     Document Type: Article

References (54)

1. E. Adamec, P.S. Mohan, A.M. Cataldo, J.P. Vonsattel and R.A. Nixon, Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease, Neuroscience 100 (2000), 663-675.
2. A.J. Anderson, S. Stoltzner, F. Lai, J. Su and R.A. Nixon, Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL, Neurobiol Aging 21 (2000), 511-524.
3. C. Ayala-Grosso, G. Ng, S. Roy and G.S. Robertson, Caspase-cleaved amyloid precursor protein in Alzheimer's disease, Brain Pathol 12 (2002), 430-441.
4. C. Behl, Apoptosis and Alzheimer's disease, J Neural Transm 107 (2000), 1325-1344.
5. H. Braak and E. Braak, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol (Berl) 82 (1991), 239-259.
6. W.R. Brown, D.M. Moody, C.R. Thore and V.R. Challa, Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis, Ann NY Acad Sci 903 (2000), 39-45.
7. C.W. Cotman and J.H. Su, Mechanisms of neuronal death in Alzheimer's disease, Brain Pathol 6 (1996), 493-506.
8. A. Delacourte, General and dramatic glial reaction in Alzheimer brains, Neurology 40 (1990), 33-37.
9. E. Engidawork, T. Gulesserian, R. Seidl, N. Cairns and G. Lubec, Expression of apoptosis related proteins in brains of patients with Alzheimer's disease, Neurosci Lett 303 (2001), 79-82.
10. I. Ferrer, R. Blanco, M. Carmona and B. Puig, Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies, J Neural Transm 108 (2001), 1397-1415.
11. I. Ferrer, M. Boada Rovira, M.L. Sanchez Guerra, M.J. Rey and F. Costa-Jussa, Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease, Brain Pathol 14 (2004), 11-20.
12. M.C. Gastard, J.C. Troncoso and V.E. Koliatsos, Caspase activation in the limbic cortex of subjects with early Alzheimer's disease, Ann Neurol 54 (2003), 393-398.
13. G.M. Halliday, K.M. Cullen, J.J. Kril, A.J. Harding and J. Harasty, Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: a quantitative study using different antisera, Neurosci Lett 209 (1996), 29-32.
14. P. Ince, D. Irving, F. MacArthur and R.H. Perry, Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body, Parkinson's disease and non-demented elderly control patients, J Neurol Sci 106 (1991), 142-152.
15. K.A. Jellinger and C. Stadelmann, Problems of cell death in neurodegeneration and Alzheimer's Disease, J Alzheimer's Dis 3 (2001), 31-40.
16. Y. Kitamura, S. Shimohama, W. Kamoshima, T. Ota, Y. Matsuoka, Y. Nomura, M.A. Smith, G. Perry, P.J. Whitehouse and T. Taniguchi, Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32 in Alzheimer's disease, Brain Res 780 (1998), 260-269.
17. K. Kobayashi, F. Muramori, T. Aoki, M. Hayashi, K. Miyazu, Y. Fukutani, M. Mukai and Y. Koshino, KP-1 is a marker for extraneuronal neurofibrillary tangles and senile plaques in Alzheimer diseased brains. Dement Geriatr Cogn Disord 9 (1998), 13-19.
18. K. Kobayashi, M. Hayashi, H. Nakano, Y. Fukutani, K. Sasaki, M. Shimazaki and Y. Koshino, Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease, Neuropathol Appl Neurobiol 28 (2002), 238-251.
19. K. Kobayashi, H. Nakano, M. Hayashi, M. Shimazaki, Y. Fukutani, K. Sasaki, K. Sugimori and Y. Koshino, Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease, J Neurol Sci 208 (2003), 17-24.
20. H. Lassmann, C. Bancher, H. Breitschopf, J. Wegiel, M. Bobinski, K. Jellinger and H.M. Wisniewski, Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ, Acta Neuropathol (Berl) 89 (1995), 35-41.
21. W.P. Li, W.Y. Chan, H.W.L. Lai and D.T. Yew, Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients, J Mol Neuroscience 8 (1997), 75-82.
22. F. Malchiodi-Albedi, M.R. Domenici, S. Paradisi, A. Bernardo, M.A. Ajmone-Cat and L. Minghetti, Astrocytes contribute to neuronal impairment in beta A toxicity increasing apoptosis in rat hippocampal neurons, Glia 34 (2001), 68-72.
23. J.A. Martin, D.K. Craft, J.H. Su, R.C. Kim and C.W. Cotman, Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion, Neurobiol Aging 22 (2000), 195-207.
24. A. Migheli, P. Cavalla, R. Piva, M.T. Giordana and D. Schiffer, Bcl-2 protein expression in aged brain and neurodegenerative diseases, Neuroreport 5 (1994), 1906-1908.
25. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle and L van Berg, and participating CERAD neuropathologists, The Consortium to Establish a Registry for Alzheimer's disease (CERAD), Part II, Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology 41 (1991), 479-486.
26. Z.S. Nagy and M.M. Esiri, Apoptosis-related protein expression in the hippocampus in Alzheimer's disease, Neurobiol Aging 18 (1997), 565-571.
27. H. Nakano, K. Kobayashi, K. Sugimori, M. Shimazaki, K. Miyazu, M. Hayashi and H. Furuta, Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease, Dement Geriatr Cogn Disord 17 (2004), 122-131.
28. J.A. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham and R.O. Weller, Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report, Nat Med 9 (2003), 448-452.
29. T. Nishimura, H. Akiyama, S. Yonehara, H. Kondo, K. Ikeda, M. Kato, E. Iseki and K. Kosaka, Fas antigen expression in brains of patients with Alzheimer-type dementia, Brain Res 695 (1995), 137-145.
30. S. Oddo, A. Caccamo, M. Kitazawa, B.P. Tseng and F.M. LaFerla, Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease, Neurobiol Aging 24 (2003), 1063-1070.
31. J.M. Orgogozo, S. Gilman, J.F. Dartigues, B. Laurent, M. Puel, L.C. Kirby, P. Jouanny, B. Dubois, L. Eisner, S. Flitman, B.F. Michel, M. Boada, A. Frank and C. Hock, Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization, Neurology 61 (2003), 46-54.
32. S. Paradisi, B. Sacchetti, M. Balduzzi, S. Gaudi and F. Malchiodi-Albedi, Astrocyte modulation of in vitro beta-amyloid neurotoxicity, Glia 46 (2004), 252-260.
33. D.P. Pelviga, H. Pakkenberga, L. Regeur, S. Osterc and B. Pakkenberga, Neocortical glial cell numbers in Alzheimer's disease. A Stereological Study, Dement Geriatr Cogn Disord 16 (2003), 212-219.
34. P. Saas, J. Boucraut, A.L. Quiquerez, V. Schnuringer, G. Perrin, S. Desplat-Jego, D. Bernard, P.R. Walker and P.Y. Dietrich, CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation? J Immunol 162 (1999), 2326-2333.
35. T. Satou, B.J. Cummings and C.W. Cotman, Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity, Brain Res 697 (1995), 35-43.
36. C. Schukla and L.R. Bridges, Regional distribution of tau, β-amyloid and β-amyloid precursor protein in the Alzheimer's brain: a quantitative immunolabeling study, NeuroReport 10 (1999), 3785-3789.
37. L.A. Selznick, T.S. Zheng, R.A. Flavell, P. Rakic and K.A. Roth, Amyloid beta-induced neuronal death is bax-dependent but caspase-independent, J Neuropathol Exp Neurol 59 (2000), 271-279.
38. G. Smale, N.R. Nichols, D.R. Brady, C.E. Finch and W.E. Horton Jr., Evidence for apoptotic cell death in Alzheimer's disease, Exp Neurol 133 (1995), 225-230.
39. C. Stadelmann, T.L. Deckwerth, A. Srinivasan, C. Bancher, W. Bruck, K. Jellinger and H. Lassmann, Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease, Evidence for apoptotic cell death, Am J Pathol 155 (1999), 1459-1466.
40. J.H. Su, J.A. Anderson and B.J. Cummings, Immunohistochemical evidence of apoptosis in Alzheimer's disease, NeuroReport 5 (1994), 2529-2533.
41. J.H. Su, T. Satou, A.J. Anderson and C.W. Cotman, Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer's disease, NeuroReport 7 (1996), 437-440.
42. J.H. Su, M. Zhao, A.J. Anderson, A. Srinivasan and C.W. Cotman, Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology, Brain Res 898 (2001), 350-357.
43. K. Sugaya, M. Reeves and M. McKinney, Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus, Neurochem Int 31 (1997), 275-281.
44. H. Takuma, T. Tomiyama, K. Kuida and H. Mori, Amyloid beta peptide-induced cerebral neuronal loss is mediated by caspase-3 in vivo, J Neuropathol Exp Neurol 63 (2004), 255-261.
45. U. Thaker, A.M. McDonagh, T. Iwatsubo, C.L. Lendon, S.M. Pickering-Brown and D.M. Mann, Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease, Neuropathol Appl Neurobiol 29 (2003), 35-44.
46. D.R. Thal, U. Rub, C. Schultz, I. Sassin, E. Ghebremedhin, K. Del Tredici, E. Braak and H. Braak, Sequence of A beta-protein deposition in the human medial temporal lobe, J Neuropathol Exp Neurol 59 (2000), 733-748.
47. A. Tortosa, E. López and I. Ferrer, Bcl-2 and Bax protein expression in Alzheimer's disease, Acta Neuropathol (Berl) 95 (1998), 407-412.
48. J. Xu, S. Chen, S.H. Ahmed, H. Chen, G. Ku, M.P. Goldberg and C.Y. Hsu, Amyloid-β peptides are cytotoxic to oligodendrocytes, J Neurosci 21(RC118) (2001), 1-5.
49. T. Yamada, Y. Tsuboi and M. Takahashi, Interrelationship between beta-amyloid deposition and complement-activated oligodendroglia, Dement Geriatr Cogn Disord 8 (1997), 267-272.
50. H. Yamaguchi, T. Yamazaki, K. Ishiguro, M. Shoji, Y. Nakazato and S. Hirai, Ultrastructural localization of Alzheimer amyloid β/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes, Acta Neuropathol (Berl) 85 (1992), 15-22.
51. H. Yamaguchi, S. Sugihara, A. Ogawa, T.C. Saido and Y. Ihara, Diffuse plaques associated with astroglial amyloid protein, possibly showing a disappearing stage of senile plaques, Acta Neuropathol (Berl) 95 (1998), 217-222.
52. W.W. Zhang, T. Badonic, A. Höög, M.H. Jiang, K.C. Ma, J.X. Nie, Y. Olsson and P. Sourander, Structural and vasoactive factors influencing intracerebral arterioles of vascular dementia and other cerebrovascular dementia, Dementia 5 (1994), 153-162.
53. Y. Zhang, C. Goodyer and A. LeBlanc, Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8, J Neurosci 20 (2000), 8384-8389.
54. M. Zhao, J. Su, E. Head and C.W. Cotman, Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease, Neurobiol Dis 14 (2003), 391-403.